title: Development of Candida albicans colitis in a child undergoing steroid therapy for ulcerative colitis.
authors.affiliation: Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan. takahi-k@qg7.so-net.ne.jp
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kudo
authors.forename: Yoh
authors.initials: Y
authors.lastname: Aoyagi
authors.forename: Tohru
authors.initials: T
authors.lastname: Fujii
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Ohtsuka
authors.forename: Satoru
authors.initials: S
authors.lastname: Nagata
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Shimizu
mesh_terms: D000293:Adolescent; D001623:Betamethasone / Q000009:adverse effects; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000139:chemically induced*; D003092:Colitis / Q000139:chemically induced* / Q000382:microbiology; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000139:chemically induced*; D011239:Prednisolone / Q000009:adverse effects
chemical_list: D005938:Glucocorticoids; D001623:Betamethasone; D011239:Prednisolone